New sedative could help preterm babies breathe on their own faster
NCT ID NCT06878703
First seen Feb 20, 2026 · Last updated Jun 22, 2026 · Updated 20 times
Summary
This study compares two sedatives, dexmedetomidine and midazolam, in very premature babies who need a breathing tube. The goal is to see if dexmedetomidine helps them come off the ventilator sooner, which could reduce lung injury. About 380 babies born before 32 weeks will take part across multiple hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM NEONATE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Armand Trousseau, APHP Service : Department of Neonatology
RECRUITINGParis, 75012, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexmedetomidine
What this could lead to
If it works, this could lead to a safer sedation option for preterm babies, helping them get off ventilators sooner and reducing lung damage.
What could go wrong
This is a phase 3 trial, but results may not apply to all preterm infants. Dexmedetomidine may not shorten breathing tube time as hoped, and side effects like low heart rate are possible.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.